DUBLIN, April 10, 2013 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/3wm73v/global_blood) has announced the addition of the "Global Blood Glucose Test Strips Market 2011-2015" report to their offering.
TechNavio's analysts forecast the Global Blood Glucose Test Strips market to grow at a CAGR of 4.57 percent in terms of revenue over the period 2011-2015. One of the key factors contributing to this market growth is the increasing diabetic population. The Global Blood Glucose Test Strips market has also been witnessing the trend of the adoption of home healthcare devices. However, the presence of non-invasive blood glucose monitoring devices in the market could pose a challenge to the growth of this market.
Key vendors dominating this market space include Abbott Diabetes Care Inc., Bayer Healthcare AG, LifeScan Inc., and Roche Diagnostics Corp.
Other vendors in the market are Hainice Medical Inc., Nipro Diagnostics Inc., and Nova Biomedical Corp.
Commenting on the report, an analyst from TechNavio's Healthcare team said: "Vendors are increasing their online marketing and promotional activities to increase sales and customer reach. This not only provides customers with easy access, but it also helps vendors reduce their set-up and operational costs. Furthermore, patients are opting for online purchases as there are no time limitations in placing orders. Thus, the increasing use of online marketing tools has a positive impact on the market."
According to the report, one of the main drivers for this market is the increase in diabetic patients across the globe. Unhealthy lifestyles, changes in diet, and lack of physical exercise have led to an increase in the prevalence of diabetes. As a result, blood glucose test strips are increasingly used to measure blood glucose levels.
For more information visit http://www.researchandmarkets.com/research/3wm73v/global_blood
|SOURCE Research and Markets|
Copyright©2012 PR Newswire.
All rights reserved